These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 398934)

  • 1. [Toxic epidermal necrosis. Review of the theme and presentation of 20 cases].
    Arellano Ocampo F; Pérez Martín MA; Rodríguez MT; Ramales E
    Med Cutan Ibero Lat Am; 1979; 7(1-3):31-43. PubMed ID: 398934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lyell syndrome in Senegal: responsibility of thiacetazone].
    Mame Thierno D; On S; Thierno Ndiaye S; Ndiaye B
    Ann Dermatol Venereol; 2001 Dec; 128(12):1305-7. PubMed ID: 11908132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management.
    Chang YS; Huang FC; Tseng SH; Hsu CK; Ho CL; Sheu HM
    Cornea; 2007 Feb; 26(2):123-9. PubMed ID: 17251797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell's syndrome).
    Guillaume JC; Roujeau JC; Revuz J; Penso D; Touraine R
    Arch Dermatol; 1987 Sep; 123(9):1166-70. PubMed ID: 3632001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications.
    Sotozono C; Ueta M; Koizumi N; Inatomi T; Shirakata Y; Ikezawa Z; Hashimoto K; Kinoshita S
    Ophthalmology; 2009 Apr; 116(4):685-90. PubMed ID: 19243825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxic epidermal necrolysis: analysis of clinical course and SCORTEN-based comparison of mortality rate and treatment modalities in Korean patients.
    Kim KJ; Lee DP; Suh HS; Lee MW; Choi JH; Moon KC; Koh JK
    Acta Derm Venereol; 2005; 85(6):497-502. PubMed ID: 16396796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients.
    Chan HL; Stern RS; Arndt KA; Langlois J; Jick SS; Jick H; Walker AM
    Arch Dermatol; 1990 Jan; 126(1):43-7. PubMed ID: 2404462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lyell's disease (author's transl)].
    Kint A; Geerts ML; de Weert J
    Dermatologica; 1981; 163(6):433-54. PubMed ID: 7333400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Toxic epidermal necrolysis].
    Jacobsen KU
    Ugeskr Laeger; 1976 Mar; 138(13):791-4. PubMed ID: 1265849
    [No Abstract]   [Full Text] [Related]  

  • 11. Uncovering histologic criteria with prognostic significance in toxic epidermal necrolysis.
    Quinn AM; Brown K; Bonish BK; Curry J; Gordon KB; Sinacore J; Gamelli R; Nickoloff BJ
    Arch Dermatol; 2005 Jun; 141(6):683-7. PubMed ID: 15967913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective, noncomparative open study from Kuwait of the role of intravenous immunoglobulin in the treatment of toxic epidermal necrolysis.
    Al-Mutairi N; Arun J; Osama NE; Amr Z; Mazen AS; Ibtesam el-A; Nazeha el-B
    Int J Dermatol; 2004 Nov; 43(11):847-51. PubMed ID: 15533072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Toxic epidermal necrolysis. Epidemiologic, clinic and therapeutic aspects at Cotonou University and National Teaching Hospital].
    Aguèmon AR; Houngbé F; Yaméogo TM; Tchaou B; Madougou S; Lokossou T; Hounkpè PC
    Ann Fr Anesth Reanim; 2006 May; 25(5):505-9. PubMed ID: 16545537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic susceptibility to toxic epidermal necrolysis.
    Roujeau JC; Huynh TN; Bracq C; Guillaume JC; Revuz J; Touraine R
    Arch Dermatol; 1987 Sep; 123(9):1171-3. PubMed ID: 3477129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [On the treatment of toxic epidermal necrolysis (Lyell syndrome) (author's transl)].
    Gutzwiller P; Schuppli R
    Dermatologica; 1973; 147(1):1-5. PubMed ID: 4756832
    [No Abstract]   [Full Text] [Related]  

  • 16. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
    Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
    Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular manifestations and complications of Stevens-Johnson syndrome and toxic epidermal necrolysis: an Asian series.
    Yip LW; Thong BY; Lim J; Tan AW; Wong HB; Handa S; Heng WJ
    Allergy; 2007 May; 62(5):527-31. PubMed ID: 17313402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxic epidermal necrolysis and intravenous immunoglobulin: a review.
    Trent J; Halem M; French LE; Kerdel F
    Semin Cutan Med Surg; 2006 Jun; 25(2):91-3. PubMed ID: 16908399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of toxic epidermal necrolysis with intravenous immunoglobulin.
    Simeone F; Rubio ER
    J La State Med Soc; 2003; 155(5):266-9. PubMed ID: 14748489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Toxic epidermal necrolysis in children (Lyell's syndrome). Apropos of 18 cases].
    Teillac D; Marsol P; Richard P; Hubert P; Roujeau JC; Cloup M; De Frost Y
    Arch Fr Pediatr; 1987 Oct; 44(8):583-7. PubMed ID: 3442460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.